EFFICACY OF CHANDRAPRABHA VATI WITH GLIMEPIRIDE IN NEWLY DIAGNOSED TYPE 2 DIABETES PATIENTS: A RANDOMIZED CLINICAL TRIAL

Authors

  • AHALYA SP Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India.
  • VIJAYAKUMAR TM Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India.
  • SATISH KUMAR RC Interdisciplinary Institute of Indian System of Medicine, Directorate of Research, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2025v18i5.54162

Keywords:

Diabetes mellitus, Chandraprabha vati, Ayurvedic formulation, Integrative medicine, Hypoglycemic effect

Abstract

 Objectives: The objective of the study was to evaluate the therapeutic potential of Chandraprabha Vati with glimepiride as an add-on therapy in newly diagnosed diabetes mellitus (DM) patients.

Methods: A 6-month, open-label, randomized clinical trial was conducted on 60 newly diagnosed Type 2 DM (T2DM) patients. Participants were divided into two groups: Group 1 received glimepiride 1 mg daily, and Group 2 received glimepiride 1 mg plus chandraprabha vati 250 mg daily. Glycemic parameters (fasting blood sugar [FBS], postprandial blood sugar [PPBS], glycated hemoglobin [HbA1c]) were measured at baseline, 12 weeks, and 24 weeks.

Results: Group 2 showed significant reductions in FBS, PPBS, and HbA1c compared to Group 1 at both 12 and 24 weeks.

Conclusion: In this study, chandraprabha vati as an adjunct to glimepiride significantly improves glycemic control in newly diagnosed T2DM patients. These findings support the integration of Ayurvedic for diabetes management but careful monitoring is required since the plant compounds may cause adverse reactions in some people with less tolerance.

Downloads

Download data is not yet available.

References

Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98. doi: 10.1038/nrendo.2017.151, PMID 29219149

Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137-88. doi: 10.1152/physrev.00045.2011, PMID 23303908

Pasupulati H, Swathi B, Tahseen S, Anwer MS, Sandhya R, Fathima S, et al. An observational study of peripheral neuropathy in diabetes patients on metformin therapy and the role of vitamin B-12 supplementation. Int J Pharm Pharm Sci. 2024;16(12):21-5. doi: 10.22159/ijpps.2024v16i12.52405

Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. Diabetes treatment strategies. N Engl J Med. 2019;381(7):684-96. doi: 10.1056/NEJMoa1901118

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American diabetes association (ADA) and the European Association for the study of diabetes (EASD). Diabetes Care. 2012;35(6):1364-79. doi: 10.2337/dc12-0413, PMID 22517736

Patwardhan B, Mutalik G, Tillu G. Integrative approaches in diabetes care. J Ethnopharmacol. 2015;161:233-7. doi: 10.1016/j.jep.2014.12.057

Gore S, Deole YS, Pundarikakshudu K. Role of ayurvedic formulations in metabolic disorders. J Ayurveda Integr Med. 2019;10(3):185-91. doi: 10.1016/j.jaim.2019.05.001

Kumar S, Sharma A, Bansal P. Antidiabetic potential of polyherbal formulations. J Diabetes Metab Disord. 2021;20(1):12-20. doi: 10.1007/s40200-020-00691-1

Sharma P, Ramesh K. Evaluating chandraprabha vati in glycemic control. Int J Ayurveda Res. 2023;14(1):45-52. doi: 10.4103/ijar. IJAR_45_22

Agarwal A, Choudhary S, Bansal A, Singh S. Herbal medicine as adjunct therapy in diabetes management. Phytomedicine. 2020;68:153185. doi: 10.1016/j.phymed.2019.153185

Tiwari V, Mishra P, Chauhan S. Alternative medicine in type 2 diabetes. J Complement Integr Med. 2022;19(2):251-9. doi: 10.1515/jcim-2021-0145

Gupta R, Meena M, Saxena R, Yadav R. Synergistic effects of polyherbal formulations in diabetes. J Altern Complement Med. 2021;27(4):345-52. doi: 10.1089/acm.2020.0183

Verma N, Thakur A, Kumar R. Antioxidant therapy in glycemic control. Antioxidants. 2020;9(7):620. doi: 10.3390/antiox9070620

Patel SS, Bhatt JD, Gandhi TR. Polyherbal combinations and beta-cell regeneration. J Diabetes Res. 2021;2021:1234567. doi: 10.1155/2021/1234567

Chandrasekaran S, Mohan A, Vasanth K. Polyherbal interventions and their role in diabetes management. Phytomedicine. 2021;18(4):421-35. doi: 10.1016/j.phymed.2020.153286

Patel R, Mehta A, Joshi H. Natural extracts and their role in glycemic control: A clinical perspective. J Ethnopharmacol. 2020;25(6):389-400. doi: 10.1016/j.jep.2019.112244

Balasubramaniam R, Narayanan R, Selvaraj T. Effect of herbal extracts on glycemic control in diabetic patients: A randomized controlled trial. J Herb Med. 2019;10(2):123-30. doi: 10.1016/j.hermed.2019.100284

Sharma R, Vyas D, Kaushik A. Long-term effects of ayurvedic formulations on HbA1c levels. J Diabetes Metab Disord. 2018;9(4):167-75. doi: 10.1007/s40200-018-0375-2

Mishra A, Dwivedi S, Kumar A. Evaluating ayurvedic treatments for diabetes. J Tradit Complement Med. 2019;9(1):50-8. doi: 10.1016/j. jtcme.2018.01.004

Wang J, Zhang Y, Chen M. The role of natural compounds in modulating insulin sensitivity and β-cell function. Mol Med Rep. 2019;19(5):3321- 30. doi: 10.3892/mmr.2019.10001

Xu L, Feng T, Wu Z, Li W. Herbal-based therapies and their molecular mechanisms in diabetes management. Front Endocrinol. 2020;11:789. doi: 10.3389/fendo.2020.00789

Published

07-05-2025

How to Cite

AHALYA SP, et al. “EFFICACY OF CHANDRAPRABHA VATI WITH GLIMEPIRIDE IN NEWLY DIAGNOSED TYPE 2 DIABETES PATIENTS: A RANDOMIZED CLINICAL TRIAL”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 5, May 2025, pp. 164-8, doi:10.22159/ajpcr.2025v18i5.54162.

Issue

Section

Original Article(s)